There is ample evidence that thyroid disease causes mood symptoms. However, little is known regarding the prevalence of hypo‐ and hyperthyroidism among mood disordered patients. Such data are necessary in order to develop rational screening strategies for reversible causes of depression. To investigate the prevalence of thyroid disease in mood disordered patients we conducted a comprehensive review of the literature to determine prevalence rate far hypo‐ and hyperthyroidism in three types of samples, focusing on clinical thyroid disease, as contrasted with sub clinical forms of the disorders for reasons discussed in detail in the body of this report. 1) In unselected general population and ambulatory medical clinic samples, prevalence rates for hypo‐ and hyperthyroidism were found to be highly dependent upon age and gender. Somatic thyroid symptoms, but not symptoms of fatigue or depression, increased the yield of thyroid Junction screening in studies which investigated the issue. 2) Two studies were available specifically on fatigued general medical samples, and only one on ambulatory depressives. Rates of hypo‐ and hyperthyroidism did not differ from the meta‐analysis‐derived prevalence rates for general population and medical clinic samples. 3) Analysis of inpatient depressive studies revealed a bimodal distribution of prevalence rates, with the bulk of studies reporting negligible rates of hypo‐ or hyperthyroidism. Sample size was modest in most of the inpatient studies, and no factors could be identified which predicted increased rates of hypo‐ or hyperthyroidism among inpatient depressives. We therefore hypothesize that although hypo‐ and hyperthyroidism produce mood symptoms in a high proportion of affected persons, major depressives may not comprise an enriched sample for hypo‐ or hyperthyroidism. If so, screening guidelines for the general population, rather than routine screening of all depressives, may be the appropriate testing strategy. Limitations of the current data are discussed in light of conceptual and methodological issues in testing strategy development. Depression 1:210‐219 (1993). © 1993 Wiley‐Liss, Inc.